Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    15003170 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Enrolling by invitation 4-Aminopyridine in Episodic Ataxia Type 2
Condition: Episodic Ataxia Type 2
Interventions: Drug: 4-Aminopyridine;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.